Literature DB >> 118112

Human serum inhibits the interaction between C1q or rheumatoid factor and IgG-coated latex particles. Reduction of these C1-dependent properties after complement activation in vitro and in vivo.

R Hällgren.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 118112      PMCID： PMC1457841     

Source DB:  PubMed          Journal:  Immunology        ISSN： 0019-2805            Impact factor:   7.397


× No keyword cloud information.
  15 in total

1.  CHROMATOGRAPHIC SEPARATION OF THE FIRST COMPONENT OF COMPLEMENT AND ITS ASSAY ON A MOLECULAR BASIS.

Authors:  T BORSOS; H J RAPP
Journal:  J Immunol       Date:  1963-12       Impact factor: 5.422

2.  Chemical studies of Clq; a modulator of immunoglobulin biology.

Authors:  K Yonemasu; R M Stroud; W Niedermeier; W T Butler
Journal:  Biochem Biophys Res Commun       Date:  1971-06-18       Impact factor: 3.575

3.  Kinetics of the agglutination of IgG-coated latex particles by C1q: the influence of heat-labile serum components.

Authors:  R Hällgren; G Stålenheim; P Venge
Journal:  Scand J Immunol       Date:  1979       Impact factor: 3.487

4.  Structural studies on human Clq: non-covalent and covalent subunits.

Authors:  K Yonemasu; R M Stroud
Journal:  Immunochemistry       Date:  1972-05

Review 5.  Complement.

Authors:  H J Müller-Eberhard
Journal:  Annu Rev Biochem       Date:  1969       Impact factor: 23.643

6.  The subunit composition and sedimentation properties of human C1.

Authors:  R J Ziccardi; N R Cooper
Journal:  J Immunol       Date:  1977-06       Impact factor: 5.422

7.  Polymer enhancement of automated immunological nephelometric analysis, as illustrated by determination of urinary albumin.

Authors:  J Lizana; K Hellsing
Journal:  Clin Chem       Date:  1974-04       Impact factor: 8.327

8.  A comparison of methods for the molecular quantitation of the fourth component of human complement.

Authors:  N R Cooper; H J Müller-Eberhard
Journal:  Immunochemistry       Date:  1968-03

9.  Circulating immune complexes in the serum in systemic lupus erythematosus and in carriers of hepatitis B antigen. Quantitation by binding to radiolabeled C1q.

Authors:  U E Nydegger; P H Lambert; H Gerber; P A Miescher
Journal:  J Clin Invest       Date:  1974-08       Impact factor: 14.808

10.  THE MACROMOLECULAR NATURE OF THE FIRST COMPONENT OF HUMAN COMPLEMENT.

Authors:  G B NAFF; J PENSKY; I H LEPOW
Journal:  J Exp Med       Date:  1964-04-01       Impact factor: 14.307
View more
  4 in total

1.  Kinetic studies of phagocytosis. III. The complement-dependent opsonic and anti-opsonic effects of normal and sle sera.

Authors:  L Håkansson; R Hällgren; P Venge
Journal:  Immunology       Date:  1982-09       Impact factor: 7.397

2.  Kinetic studies of the association of complement components and IgG-coated latex particles incubated in normal or complement-activated human serum.

Authors:  R Hällgren
Journal:  Clin Exp Immunol       Date:  1981-04       Impact factor: 4.330

3.  Enzyme immunoassay of complement-binding rheumatoid factors.

Authors:  A M Teppo; C P Maury
Journal:  Rheumatol Int       Date:  1986       Impact factor: 2.631

4.  Complement-mediated inhibition of immune precipitation. I. Role of the classical and alternative pathways.

Authors:  J A Schifferli; P Woo; D K Peters
Journal:  Clin Exp Immunol       Date:  1982-03       Impact factor: 4.330
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.